Pediatricians near Passaic, NJ

Biography: Dr. Kravitz is originally from London, Ontario, Canada. She graduated with honors from University of Michigan, where she studied Biopsychology, Cognition, and Neuroscience. She earned her medical degree at the Charles E. Schmidt College of Medicine in Boca Raton, Florida, where she was elected to the Alpha Omega Alpha and Gold Humanism Honor Societies. She completed her residency training at Columbia University Medical Center/Morgan Stanley Children's Hospital in New York City prior to joining the Weill Cornell team on the Upper West Side.

Biography: Dr. Odom was born and raised on the Upper West Side and attended The Dalton School. She matriculated at Washington University in St. Louis for college, where she studied Biology, with a focus on Neuroscience, and graduated with honors. She returned to New York upon graduation and worked as a high school teacher prior to beginning medical school. She earned her medical degree from the Icahn School of Medicine at Mount Sinai and stayed to complete her residency at Mount Sinai Kravis Children's Hospital. Upon completing her training in general pediatrics, Dr. Odom joined Weill Cornell Medicine. She has a vast array of interests in general pediatrics and is particularly interested in preventative care. As a Certified Lactation Counselor, Dr. Odom is additionally passionate about assisting families who want to breastfeed.

Biography: Dr. Nestler went to college at Wesleyan University, where she studied Psychology. She earned her medical degree from Icahn School of Medicine at Mount Sinai where she was admitted through Humanities and Medicine, a program that guarantees humanities students from select liberal arts schools admission to the school after their sophomore year. She completed her pediatric residency training at New York Presbyterian Hospital-Weill Cornell Medical Center. Her interests include preventive care, developmental pediatrics and mental health.

Biography: Dani Dumitriu, MD, PhD, is trained as a general pediatrician, neuroscientist, and pediatric environmental health scientist. She joined Columbia University as an Associate Professor of Pediatrics (in Psychiatry) in November 2018. She dedicates 80% of her time to basic science research into the neurobiological basis of resilience as the Principal Investigator of the DOOR lab (Developmental Origins of Resilience lab) at the New York State Psychiatric Institute and 20% time to caring for newborns in the Well-Baby Nursery at the Morgan Stanley Children's Hospital of New York. The overarching goal of Dr. Dumitriu's research program is to understand and harness the neurocircuits of resilience to spearhead novel approaches to primary prevention. This is motivated by the observation that during the last century, medicine has made unprecedented progress in the treatment of disease, with a lack of parallel advancement in the prevention of disease. Consequently, the largest current worldwide disease burden comes from preventable mental and physical illnesses, such as depression, anxiety, diabetes, and hypertension. Stressful life events, particularly during critical developmental periods, have been linked to increased risk of virtually all diseases, including metabolic and cardiovascular ones, and a significant effort is underway to understand stress-induced biological consequences. However, even in the presence of the most severe stressors, some individuals remain resistant to the development of stress-induced pathology. Identifying the neurobiological basis for this natural resilience can therefore lead to the development of novel preventative strategies aimed at strengthening resiliency circuits. To tackle the mechanisms for individual variability in stress-responses, the DOOR lab uses several animal models, with the overarching unifying goal of understanding the structure, function, and Developmental Origins of Resilience. In a mouse model of adult social defeat stress, we dissect preexisting neurocircuit structure-function differences in susceptible versus resilient animals using state-of-the-art tools including in vivo chemogenetics, optogenetics, and miniscope imaging, ex vivo super-resolution imaging of dendritic spines, ex vivo whole-brain imaging of functional or structural connectivity using a variety of genetic and/or viral labeling tools, and graph theoretical analysis of co-activation patterns as a proxy for functional connectomics. In a separate set of experiments, we combine rat early-life maternal separation with wireless EEG and/or EKG recordings in dams and their pups. This data is used to understand individual variability in developmental trajectories and the role of dam-pup autonomic synchrony as a potential protective factor. Parallel EKG recordings and synchrony analyses are being conducted during mother-infant interactions in the newborn nursery. Finally, the lab is spearheading a study on wild rat stress-responses, asking the simple question: do depressive-like states occur in the wild, or are they a genetic and environmental epiphenomenon of laboratory breeding? In addition to answering questions about the neurobiological basis for resilience, the DOOR lab is committed to the development of new tools and to the movement toward #openscience. In collaborative work with two different engineering groups, we are developing novel wireless telemetry devices for wild rats and a robotic solution for ex vivo neuronal microinjections. Recently, we also launched a website, MouseCircuits.org, as an open science repository of chemogenetic and optogenetic circuit dissection. LinksMouseCircuits.orgwww.ps.columbia.edu/COMBO

Care Philosophy: Augusta University Health is a world class health care network offering the most comprehensive care in the region where your health is our priority As leaders in patient and family centered care our physicians partner with our patients their famil

Biography: Dr. Justine Kahn is a Pediatric Oncologist and a clinical investigator specializing in survival outcomes, cancer care delivery, and health equity in children and adolescent/young adults (AYA) with Hodgkin lymphoma, non-Hodgkin lymphoma, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Dr. Kahn received her MD from the Icahn School of Medicine at Mount Sinai in New York and completed her Pediatric Residency at Mount Sinai Kravis Children's Hospital in New York. Dr. Kahn completed her Clinical Fellowship in Pediatric Hematology/Oncology at Columbia University Medical Center. While in residency, Dr. Kahn was elected to Alpha Omega Alpha, the national medical honor society which recognizes high educational achievement. During her fellowship, Dr. Kahn served as a Postdoctoral Research Fellow in Cancer-Related Population Sciences supported by the National Cancer Institute for her work in cancer care delivery, health equity, and health outcomes research. Upon graduation from fellowship, Dr. Kahn joined the Pediatric Hematology/Oncology Division at Columbia University Medical Center as an Oncology Instructor and Attending Physician in 2016. She is currently involved in patient care, clinical trials research, and health outcomes research. In June of 2018, Dr. Kahn obtained a Master of Science in Patient Oriented Research at the Columbia Mailman School of Public Health. In July of 2018 she became an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology/Stem Cell Transplantation. Dr. Kahn is actively conducting research through studies developed in the Dana-Farber Cancer Institute (DFCI) ALL Consortium, the Children's Oncology Group (COG), and at Columbia University. Columbia boasts a strong commitment to health disparities research in one of the most diverse patient populations in the United States. Dr. Kahn has chosen to focus her research efforts on underserved populations because studies suggest that poor access-to-care, low health literacy, and financial stress can all negatively impact survival in children and AYAs with cancer. Dr. Kahn is supported in part by the Lymphoma Research Foundation and recently received an institutional Career Development Award for her ongoing work on survival disparities in children and AYAs with Hodgkin lymphoma. She serves as CUMC site Principal Investigator for the DFCI ALL Consortium.

Biography: Monica Bhatia, MD specializes in the care of children with noncancerous blood disorders who may benefit from bone marrow transplantation, especially sickle cell anemia. She and her colleagues are working to reduce the toxicity (side effects) and complications of this treatment without compromising its effectiveness, and to make it available to more patients. The field of pediatric hematology brings with it many intellectual challenges, and bone marrow transplantation in particular is especially dynamic. Dr. Bhatia has the opportunity to provide care for the sickest children, potentially curing their disease. She builds strong relationships with her patients and their families that last for years. It is inspiring for her to see young patients grow up to lead healthy, productive lives. NewYork-Presbyterian/Morgan Stanley Children's Hospital has a robust program for bone marrow transplantation for sickle cell anemia - the only cure for this disease. Dr. Bhatia and her team have witnessed remarkable results among children who are cured with bone marrow transplantation and spared from the potentially life-threatening complications of sickle cell disease. Yet despite the advances made, only 15 percent of patients with sickle cell disease have a matched sibling bone marrow donor. Therefore, Dr. Bhatia and her team conduct research to evaluate a procedure called "CD34-selected stem cell transplantation" to remove T-cells from donor bone marrow for patients without a matched sibling donor. This approach reduces the risk of graft-versus-host disease (GVHD), a potential complication of bone marrow transplantation in which T-cells from the donor attack the tissue of the recipient. This approach to harnessing stem cells could potentially make bone marrow transplantation a safer, effective option for many patients who are seeking a cure for sickle cell disease. Dr. Bhatia and her colleagues are currently assessing reduced-intensity transplantation, which uses lower doses of chemotherapy to decrease the risk of side effects and long-term complications without lowering the effectiveness of treatment. She is also interested in looking for ways to further improve the quality of life of patients who have had a bone marrow transplant in addition to fertility preservation.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Dr. Sridharamurthy grew up in Queens, NY and graduated from the combined BS/MD program at the Sophie Davis School of Biomedical Education. She earned her medical degree at Albany Medical College and completed her Pediatrics residency training at Baystate Medical Center in Massachusetts. She is interested in preventative care and pediatric education.

Biography: Dr. Gaya Aranoff, MD is an Endocrinology, Diabetes /amp Metabolism Specialist who practices in New York, NY. Dr. Gaya Aranoff, MD is affiliated with Newyork-Presbyterian/Morgan Stanley Children's Hospital and Newyork-Presbyterian/Columbia University Medical Center.

Biography: Dr. Lauren Sanlorenzo, MD is a Pediatric Critical Care Medicine Specialist who practices in New York, NY. She is 43 years old and has been practicing for 15 years. Dr. Lauren Sanlorenzo, MD is affiliated with Newyork-Presbyterian/Morgan Stanley Children's Hospital, New York-Presbyterian Hospital/Lawrence and Newyork-Presbyterian/Columbia University Medical Center.

Biography: Dr. Kathleen Hardart, MD is a Pediatrics Specialist who practices in New York, NY. She is 57 years old and has been practicing for 30 years. Dr. Kathleen Hardart, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center, Newyork-Presbyterian/Morgan Stanley Children's Hospital and New York-Presbyterian Hospital/Lawrence.

Biography: Dr. Oliver Barry, MD is a Pediatrics Specialist who practices in New York, NY. He has been practicing for 16 years. Dr. Oliver Barry, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Dr. Nicolino Valerio Dorrello is an Assistant Professor in the Division of Pediatric Critical Care Medicine, Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons since 2015. He obtained his MD from University of Naples (Italy) in 2000 and his PhD in Molecular Oncology at New York University in 2004, focusing on the role of ubiquitin mediated proteolysis in cell cycle regulation. He then completed a residency in Pediatrics at the University of Padua (Italy) in 2010 and a subsequent pediatric residency at Columbia University before staying for his Fellowship in Pediatric Critical Care Medicine and then as faculty. Dr. Dorrello is double board certified in Pediatrics and Pediatric Critical Care in Unites States and in Pediatrics in Europe. In his clinical duties in the pediatric critical care unit, one of the most devastating and common injuries he comes across, unfortunately, is severe, progressive lung injury. What represents a daily clinical challenge making these patients better has become his research passion. He has recently succeeded in developing an airway-specific method to efficiently remove only the lung epithelium (de-epithelialization) while preserving lung vasculature and architecture in anex vivo rodent model. This new functional, vascularized lung graft then enabled the attachment and engraftment of lung epithelial progenitors. Dr. Dorrello's laboratory is focused on elucidating the optimal strategies to selectively remove defective lung epithelial cells and supportthe proliferation and differentiation of lung progenitors towards healthy epithelium and ultimately lung repair. Dr. Dorrello has published in international peer -reviewed journals of highest reputation, such as Science, Nature, Molecular Cell, PNAS, and Science Advances.

Biography: Dr. Candace Johnson, MD is a Pediatric Infectious Disease Specialist who practices in New York, NY. Dr. Candace Johnson, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center, Newyork-Presbyterian/Morgan Stanley Children's Hospital and New York-Presbyterian Hospital/Lawrence.

Biography: Marc Richmond, MD, MS is an Associate Professor of Pediatrics at CUMC, and the Associate Medical Director of the Program for Pediatric Cardiomyopathy, Heart Failure and Transplantation. He specializes in caring for the child with heart failure due to cardiomyopathy, congenital heart disease or acquired cardiac disorders as well as caring for children after heart transplantation for such indications. Dr. Richmond additionally sees patients as part of the Cardiac Genetics Program and in the Comprehensive Muscular Dystrophy Clinic. His clinical and research interests are focused upon improving clinical outcomes for children with heart failure or transplantation, evaluating cardiac function using newer noninvasive techniques as well as an interest in the use of ventricular assist devices for children with severe decompensated heart failure. Furthermore, he serves as the Vice-President of the multi-center Pediatric Heart Transplant Study Group and is actively involved in the multi-center Pediatric Heart Network and Cooperative Clinical Trials in Pediatric Transplantation.

Biography: Dr. Pooja Reddy Spector is an Assistant Professor of Pediatrics in the Division of Gastroenterology, Hepatology and Nutrition at Columbia University Irving Medical Center and an Attending Pediatrician at NewYork-Presbyterian Morgan Stanley Children's Hospital. She practices in the Center for Liver Disease and Transplantation. Prior to her faculty appointment, Dr. Spector earned a BA in Economics from the University of Virginia prior to pursuing her medical education at Emory University School of Medicine. She completed her residency in Pediatrics at The Children's Hospital at Montefiore and clinical fellowships in Pediatric Gastroenterology and Advanced Transplant Hepatology at NewYork-Presbyterian Columbia University Medical Center. During this time, she pursued formal training in Patient Safety research and earned a Master's degree in Epidemiology from the Columbia University Mailman School of Public Health. Dr. Spector is board certified in Pediatrics, Pediatric Gastroenterology, and Pediatric Transplant Hepatology. Dr. Spector's clinical practice is focused on the management of pediatric patients with a range of liver diseases including neonatal cholestasis, biliary atresia, rare metabolic diseases, viral hepatitis, liver tumors including hepatoblastoma, and autoimmune liver disease. She has completed advanced training in the management of pediatric liver and intestinal failure and is experienced in caring for patients both prior to and after undergoing liver, intestinal and multi-visceral transplants. Dr. Spector performs several procedures including percutaneous liver biopsy, endoscopy, variceal band-ligation and colonoscopy. While caring for patients, she aims to educate both her patients and their families as they work together toward shared decision-making and optimal treatment outcomes. Dr. Spector's research interests include patient safety, quality improvement and assurance, as well as epidemiology and outcomes of pediatric liver diseases and transplant. During her time as a Patient Safety Research Fellow, she focused on utilizing health information technology to prevent medical errors and improve the quality and efficiency with which patient care is delivered. She continues this work as part of the Empire Clinical Research Investigator Program (ECRIP).

Biography: Dr. Thomas Connors, MD is a Pediatrics Specialist who practices in New York, NY. Dr. Thomas Connors, MD is affiliated with Newyork-Presbyterian/Morgan Stanley Children's Hospital and Newyork-Presbyterian/Columbia University Medical Center.